| 000 | 01105 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250511161053.0 | ||
| 264 | 0 | _c19761121 | |
| 008 | 197611s 0 0 eng d | ||
| 022 | _a0340-0026 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLavene, D | |
| 245 | 0 | 0 |
_aDrug interactions of the components of Optalidon after oral administration. _h[electronic resource] |
| 260 |
_bInternational journal of clinical pharmacology and biopharmacy _cJun 1976 |
||
| 300 |
_a235-45 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAminopyrine _xadministration & dosage |
| 650 | 0 | 4 |
_aBarbiturates _xadministration & dosage |
| 650 | 0 | 4 |
_aCaffeine _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMale |
| 700 | 1 | _aLongchampt, J | |
| 700 | 1 | _aGuillaume, M F | |
| 700 | 1 | _aKiger, J L | |
| 773 | 0 |
_tInternational journal of clinical pharmacology and biopharmacy _gvol. 13 _gno. 4 _gp. 235-45 |
|
| 999 |
_c972661 _d972661 |
||